Merged company faces generics threats
Ortho-Biotech to market cancer drug
Deal welcomed by analysts
Reminder given about dosage levels
GSK increases stake in US biotech
Lack of funding a major problem
AstraZeneca adds to oncology franchise
BMS looks to build long-term growth
NICE aims for greater transparency